Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes - Ramos-Álvarez, I; Martín-Duce, A; Moreno-Villegas, Z; Sanz, R; Aparicio, C; Portal-Núñez, S; Mantey, S A; Jensen, R T; González, N (Mol Cell Endocrinol, 2013)